Back

Usefulness of a new risk score in identifying patients with CML at increased risk of cardiovascular toxicities

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Cardiovascular Disease in Special Populations ePosters Cardio-Oncology ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Giulia Alagna

G. Martino University Hospital, Messina (Italy)

187 More presentations in this session

Presentation thumbnail
The effects of dapagliflozin on kidney and cardiovascular outcomes in patients with chronic kidney disease with and without heart failure
Professor J. McMurray (Glasgow, GB)
Abstract Slides
Presentation thumbnail
CHA2DS2-VASc score as independent outcome predictor in patients with acute ischemic stroke with and without atrial fibrillation
Doctor C. Su (Taichung, TW)
Abstract Slides
Presentation thumbnail
Type and severity of migraine determines long-term risk of atrial fibrillation in women: a nationwide population-based study
Doctor T. Rhee (Seoul, KR)
Abstract Slides
Presentation thumbnail
Association between renal function and clinical outcomes in elderly patients with nonvalvular atrial fibrillation: sub-analysis of the ANAFIE Registry
Professor W. Shimizu (Matsudo, JP)
Abstract Slides
Presentation thumbnail
The impact of maternal hypothyroidism on the prevalence of preeclampsia in a contemporary nationwide cohort.
Doctor S. Alampoondi Venkataramanan (Worcester, US)
Abstract Slides

Access the full session

Session thumbnail
Cardiovascular Disease in Special Populations ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular toxicity in CML patients treated with BCR-ABL inhibitors: relevance of early detection and management of cardiovascular follow-up
21 June 2025
thumbnail
Congress Presentation
Assessment of CV risk by SCORE2 with an online calculator estimates CV risk better compared to 2-dimensional risk charts
3 April 2025
thumbnail
Webinar
ACVC Biomarker Talk Series - Biomarkers in atrial fibrillation
24 November 2021
thumbnail
Congress Presentation
Predictive capacity of the HFA-ICOS risk stratification scale for cardiovascular adverse events in patients treated with proteasome inhibitors
21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources